Results 91 to 100 of about 115,117 (314)

A review of the use of somatostatin analogs in oncology

open access: yesOncoTargets and Therapy, 2013
Somatostatin is a neuropeptide produced by paracrine cells that are located throughout the gastrointestinal tract, lung, and pancreas, and is also found in various locations of the nervous system.
O. Keskin, Ş. Yalçın
semanticscholar   +1 more source

Neural circuitry of rapid eye movement sleep homeostasis: Mechanistic insights and pathological implications

open access: yesSleep Research, EarlyView.
Abstract Rapid eye movement (REM) sleep is a unique brain state crucial for emotion, memory, and plasticity. Unlike well‐understood non‐REM (NREM) sleep homeostasis, REM sleep homeostasis remains less clearly defined. This review highlights recent progress in understanding REM sleep homeostasis, focusing on its neurophysiological markers, neural ...
Ting He
wiley   +1 more source

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

open access: yesEndocrine-Related Cancer, 2010
Somatostatin receptor imaging (SRI) with [(111)In-DTPA(0)]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs).
D. Kwekkeboom   +8 more
semanticscholar   +1 more source

Radiolabeled Nanogels: From Multimodality Imaging to Combination Therapy of Cancer

open access: yesSmall Science, EarlyView.
Nanogel refers to nanosized particles formed by physical or chemical crosslinking of polymers. Rational design and refinement of nanogel properties are imperative to unlock their full potential, ensuring tailored solutions for personalized cancer management. This review elucidates the transformative potential of radiolabeled nanogels in revolutionizing
Sanchita Ghosh   +2 more
wiley   +1 more source

Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

open access: yesActa Ophthalmologica, EarlyView.
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs   +12 more
wiley   +1 more source

Computerised Algorithms Showed Promise in Identifying Swedish Children With Atypical Growth Patterns

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim We used computerised algorithms comparing the performance of the growth assessment criteria recommended in Sweden with those used in Finland and established by the International Obesity Task Force (IOTF). Methods Historical data from 3214 Swedish children (51.6% girls) at 4, 6, and 8 years of age were compared with five Finnish screening ...
Lars Gelander   +7 more
wiley   +1 more source

Knocking Out SST Gene of BGC823 Gastric Cancer Cell by CRISPR/Cas9 Enhances Migration, Invasion and Expression of SEMA5A and KLF2

open access: yesCancer Management and Research, 2020
Wei Chen, 1 Ruixian Ding, 1 Jinlu Tang, 1 Haodong Li, 2 Chonghua Chen, 2 Yaru Zhang, 1 Qinxian Zhang, 1 Xiaoyan Zhu 1 1Department of Histology and Embryology, School of Basic Medical Sciences, Zhengzhou University, Henan, People’s Republic of ...
Chen W   +7 more
doaj  

Somatostatin Release from Isolated Perfused Rat Pancreas: Possible Role of Endogenous Somatostatin on Insulin Release [PDF]

open access: green, 1979
Seizo Kadowaki   +9 more
openalex   +1 more source

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.

open access: yesJournal of Clinical Oncology, 2005
PURPOSE There are few treatment options for patients with metastasized or inoperable endocrine gastroenteropancreatic (GEP) tumors. Chemotherapy can be effective, but the response is usually less than 1 year.
D. Kwekkeboom   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy